Log In
Print
BCIQ
Print
Print this Print this
 

Opsumit, macitentan (formerly ACT-064992, Actelion-1)

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionTissue-targeting endothelin receptor antagonist
Molecular Target Endothelin receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today